(Q40097001)

17 September 2017

title

Dilute blood clot lysis time and electrophoretic lipoprotein fractions in a population sample of healthy Romanians (English)

1 reference

https://api.crossref.org/works/10.1016/0021-9150(77)90053-3

29 May 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A197975

Cardiology and cardiovascular medicine

29 May 2022

1 reference

https://api.crossref.org/works/10.1016/0021-9150(77)90053-3

29 May 2022

author name string

T. A. Popescu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A197975

29 May 2022

C. Stef

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A197975

29 May 2022

G. Moraru

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A197975

29 May 2022

M. P. Cucuianu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A197975

29 May 2022

language of work or name

1 reference

1 June 1977

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:0021915077900533?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0021-9150(77)90053-3

https://api.elsevier.com/content/article/PII:0021915077900533?httpAccept=text/plain

29 May 2022

1 reference

https://api.crossref.org/works/10.1016/0021-9150(77)90053-3

29 May 2022

1 reference

17 September 2017

volume

27

1 reference

17 September 2017

issue

2

1 reference

17 September 2017

page(s)

155-163

1 reference

Impaired fibrinolytic response to exercise in patients with type-IV hyperlipoproteinaemia.

17 September 2017

cites work

5

1 reference

https://api.crossref.org/works/10.1016/0021-9150(77)90053-3

Fibrinolytic activity; inhibition of plasminogen activation

29 May 2022

7

1 reference

https://api.crossref.org/works/10.1016/0021-9150(77)90053-3

Serum pseudocholinesterase and ceruloplasmin in various types of hyperlipoproteinemia

29 May 2022

13

1 reference

https://api.crossref.org/works/10.1016/0021-9150(77)90053-3

Colorimetric method for the determination of serum cholinesterase

29 May 2022

14

1 reference

https://api.crossref.org/works/10.1016/0021-9150(77)90053-3

The influence of various plasma components on the lysis of dilute human blood clots

29 May 2022

15

1 reference

https://api.crossref.org/works/10.1016/0021-9150(77)90053-3

DETERMINATION OF SERUM TRIGLYCERIDES

29 May 2022

17

1 reference

https://api.crossref.org/works/10.1016/0021-9150(77)90053-3

Serum lipids in normal men

29 May 2022

19

1 reference

https://api.crossref.org/works/10.1016/0021-9150(77)90053-3

Quantitative and qualitative serum lipoprotein analysis. Part 1. Studies in healthy men and women

29 May 2022

20

1 reference

https://api.crossref.org/works/10.1016/0021-9150(77)90053-3

Frequency of risk factors for ischaemic heart-disease in a healthy British population. With particular reference to serum-lipoprotein levels

29 May 2022

21

1 reference

https://api.crossref.org/works/10.1016/0021-9150(77)90053-3

Serum lipid and lipoprotein concentrations in a Norwegian population sample

29 May 2022

22

1 reference

https://api.crossref.org/works/10.1016/0021-9150(77)90053-3

Resting levels of blood fibrinolysis in hyperlipoproteinemia

29 May 2022

25

1 reference

https://api.crossref.org/works/10.1016/0021-9150(77)90053-3

Positive correlation of serum lecithin: cholesterol acyltransferase activity with relative body weight

29 May 2022

26

1 reference

https://api.crossref.org/works/10.1016/0021-9150(77)90053-3

Gamma-glutamyl transpeptidase, triglycerides, and enzyme induction

29 May 2022

27

1 reference

https://api.crossref.org/works/10.1016/0021-9150(77)90053-3

29 May 2022

Identifiers

1 reference

17 September 2017

1 reference